Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2017-08-08

Clinical Trial Update: Evaluation Exparel Delivered in Knee Replacement [Phase 4]

View source ↗

Summary

Phase 4 trial evaluating Exparel for pain control in knee replacement has completed and results have been posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Exparel (liposomal bupivacaine)

Snippet

Sponsor: Maimonides Medical Center | Conditions: Arthritis | Phase 4 | Status: COMPLETED | Results posted: 2017-08-08